MedPath

Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Not Applicable
Completed
Conditions
General Anesthesia
Breast Disease
Interventions
Drug: use of rocuronium when the LMA is inserted
Registration Number
NCT01035021
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • 18-70 year
  • american society of anesthesiologist status 1-2
  • elective general anesthesia
Exclusion Criteria
  • known or predicted difficult airway
  • recent sore throat
  • mouth opening less than 2.5 cm
  • at risk of aspiration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group Nuse of rocuronium when the LMA is insertedAnesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation.
group Ruse of rocuronium when the LMA is insertedAnesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.
Primary Outcome Measures
NameTimeMethod
success rate and insertion timewhen laryngeal mask airway is inserted
Secondary Outcome Measures
NameTimeMethod
complication after the remove of LMA - bleeding, sore throat1 hour after the LMA is removed

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath